Is IBO up or down today?
IBO is up 7.32% today, last at 4.40. This stock moved +7.32% versus the prior close.
IBO · IBO
IBO (IBO) is trading at 4.40, up 7.32% on the session. IBO sits at the 25% mark of its 52-week range, carries a 14-day RSI of 53, and trades below its 50-day average. Over the past month it is down 5.98%.
Leading the coverage: “12 Health Care Stocks Moving In Wednesday's After-Market Session” (Benzinga, 22d ago). IBO is +18.13% since story.
IBO trades on a trailing P/E of 44.9 and is running 0.06% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
IBO is up 7.32% today, last at 4.40. This stock moved +7.32% versus the prior close.
Leading the coverage: “12 Health Care Stocks Moving In Wednesday's After-Market Session” (Benzinga, 22d ago). IBO is +18.13% since story. Dominant story: DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited (3 sources, neutral) RSI is 53 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
A vote on Impact Biomedical’s proposed merger is set for Nov. 13 - Stock Titan
Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination - Yahoo Finance
Impact BioMedical(IBO) Stock Options Chain | Quotes & News - Moomoo